At the virtual San Antonio Breast Cancer Symposium, researchers presented results from research on real-world sequential and non-sequential use of CDK4/6…
Patients with ultra-low-risk breast cancer according to genomic assessment had excellent long-term outcomes regardless of clinical risk or whether they…
Patients with ultralow-risk breast cancer according to genomic assessment had excellent long-term outcomes regardless of clinical risk or whether they received adjuvant therapy, a…